Page 30 - JCTR-11-2

Journal of Clinical and
Translational Research US-mediated drug delivery

69. Epelbaum S, Burgos N, Canney M, et al. Pilot study of 80. Choi JJ, Pernot M, Small SA, Konofagou EE. Noninvasive,
repeated blood-brain barrier disruption in patients with transcranial and localized opening of the blood-brain
mild Alzheimer’s disease with an implantable ultrasound barrier using focused ultrasound in mice. Ultrasound Med
device. Alzheimers Res Ther. 2022;14(1):40. Biol. 2007;33(1):95-104.
doi: 10.1186/s13195-022-00981-1 doi: 10.1016/j.ultrasmedbio.2006.07.018
70. Wei KC, Chu PC, Wang HYJ, et al. Focused ultrasound- 81. Burns S, Selman A, Sehar U, Rawat P, Reddy AP, Reddy PH.
induced blood-brain barrier opening to enhance Therapeutics of Alzheimer’s disease: Recent developments.
temozolomide delivery for glioblastoma treatment: Antioxidants (Basel). 2022;11(12):2402.
A preclinical study. PLoS One. 2013;8(3):e58995.
doi: 10.3390/antiox11122402
doi: 10.1371/journal.pone.0058995
82. Khan T, Waseem R, Shahid M, et al. Recent advancement in
71. Chen KT, Wei KC, Liu HL. Focused ultrasound combined therapeutic strategies for Alzheimer’s disease: Insights from
with microbubbles in central nervous system applications. clinical trials. Ageing Res Rev. 2023;92:102113.
Pharmaceutics. 2021;13(7):1084.
doi: 10.1016/j.arr.2023.102113
doi: 10.3390/pharmaceutics13071084
83. Raymond SB, Treat LH, Dewey JD, McDannold NJ,
72. Chen KT, Lin YJ, Chai WY, et al. Neuronavigation-guided Hynynen K, Bacskai BJ. Ultrasound enhanced delivery of
focused ultrasound (NaviFUS) for transcranial blood-brain molecular imaging and therapeutic agents in Alzheimer’s
barrier opening in recurrent glioblastoma patients: Clinical disease mouse models. PLoS One. 2008;3(5):e2175.
trial protocol. Ann Transl Med. 2020;8(11):673.
doi: 10.1371/journal.pone.0002175
doi: 10.21037/atm-20-344
84. Liu Y, Gong Y, Xie W, et al. Microbubbles in combination
73. Huang Y, Hynynen K. MR-guided focused ultrasound for with focused ultrasound for the delivery of quercetin-
brain ablation and blood-brain barrier disruption. Methods modified sulfur nanoparticles through the blood brain
Mol Biol. 2011;711:579-593. barrier into the brain parenchyma and relief of endoplasmic
doi: 10.1007/978-1-61737-992-5_30 reticulum stress to treat Alzheimer’s disease. Nanoscale.
2020;12(11):6498-6511.
74. Lipsman N, Meng Y, Bethune AJ, et al. Blood-brain barrier
opening in Alzheimer’s disease using MR-guided focused doi: 10.1039/c9nr09713a
ultrasound. Nat Commun. 2018;9(1):2336. 85. Sun T, Shi Q, Zhang Y, et al. Focused ultrasound with anti-
doi: 10.1038/s41467-018-04529-6 pGlu3 Aβ enhances efficacy in Alzheimer’s disease-like
mice via recruitment of peripheral immune cells. J Control
75. Mainprize T, Lipsman N, Huang Y, et al. Blood-brain Release. 2021;336:443-456.
barrier opening in primary brain tumors with non-invasive
MR-guided focused ultrasound: A clinical safety and doi: 10.1016/j.jconrel.2021.06.037
feasibility study. Sci Rep. 2019;9(1):321. 86. Bathini P, Sun T, Schenk M, Schilling S, McDannold NJ,
doi: 10.1038/s41598-018-36340-0 Lemere CA. Acute effects of focused ultrasound-induced
blood-brain barrier opening on anti-pyroglu3 A beta
76. Abrahao A, Meng Y, Llinas M, et al. First-in-human trial of antibody delivery and immune responses. Biomolecules.
blood-brain barrier opening in amyotrophic lateral sclerosis 2022;12(7):951.
using MR-guided focused ultrasound. Nat Commun.
2019;10(1):4373. doi: 10.3390/biom12070951
doi: 10.1038/s41467-019-12426-9 87. Burgess A, Dubey S, Yeung S, et al. Alzheimer disease in
a mouse model: MR imaging-guided focused ultrasound
77. Soria Lopez JA, González HM, Léger GC. Alzheimer’s targeted to the hippocampus opens the blood-brain barrier
disease. Handb Clin Neurol. 2019;167:231-255. and improves pathologic abnormalities and behaviour.
doi: 10.1016/B978-0-12-804766-8.00013-3 Radiology. 2014;273(3):736-745.
78. Wimo A, Winblad B, Aguero-Torres H, von Strauss E. The doi: 10.1148/radiol.14140245
magnitude of dementia occurrence in the world. Alzheimer 88. Jordão JF, Ayala-Grosso CA, Markham K, et al. Antibodies
Dis Assoc Disord. 2003;17(2):63-67. targeted to the brain with image-guided focused
doi: 10.1097/00002093-200304000-00002 ultrasound reduces amyloid-beta plaque load in the
TgCRND8 mouse model of Alzheimer’s disease. PLoS
79. Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K.
Alzheimer’s disease drug development pipeline: 2020. One. 2010;5(5):e10549.
Alzheimers Dement (N Y). 2020;6(1):e12050. doi: 10.1371/journal.pone.0010549
doi: 10.1002/trc2.12050 89. Dubey S, Heinen S, Krantic S, et al. Clinically approved

Volume 11 Issue 2 (2025) 24 doi: 10.36922/jctr.24.00061